Clinical trial
Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
NCT01772719 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
- Lead sponsor
- University of Louisville
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 31, 2012
- Completion date
- November 30, 2016
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.